• Berberrubine Chloride: Protocols for Cancer & Metabolic Rese

  2026-06-18

  Berberrubine chloride enables multi-pathway targeting in cancer, inflammation, and metabolic disease models, with robust protocols for both in vitro and in vivo studies. This article decodes applied workflows, troubleshooting, and the impact of structure-activity insights to maximize rigor and reproducibility in translational research.

• NF 449 Reveals P2X1 Receptor's Role in Platelet Activation a

  2026-06-18

  The reference study establishes NF 449 as a highly selective purinergic receptor antagonist, enabling precise dissection of P2X1-mediated platelet functions in vitro and in vivo. These findings clarify the distinct contribution of the P2X1 ion channel to platelet activation, aggregation, and thrombus formation, and highlight NF 449's value for targeted antithrombotic research.

• Structural Mechanisms of ASCH Domain Proteins in N4-Acetylcy

  2026-06-17

  Meng et al. present a comprehensive structural analysis of ASCH domain-containing proteins, revealing the catalytic mechanism and substrate specificity of the E. coli amidohydrolase EcYqfB in converting N4-acetylcytidine to cytidine. These findings clarify the roles of ASCH family proteins in nucleotide metabolism and provide a foundation for RNA epigenetics and post-transcriptional modification research.

• 740 Y-P: PI 3-Kinase Activator for Vesicular and Neuronal Re

  2026-06-17

  740 Y-P offers precise, rapid activation of the PI3K/AKT pathway for dissecting vesicular trafficking and neuronal survival mechanisms. Researchers can streamline apoptosis assays and troubleshoot signaling workflows using APExBIO's robust, cell-permeable PI 3-kinase activator.

• Nanoparticle Physicochemical Properties Drive Corneal Uptake

  2026-06-16

  This study reveals how nanoparticle size and surface chemistry critically influence the uptake mechanisms in human corneal epithelial cells. Insights into endocytic pathways and optimal nanoparticle design offer a foundation for more effective ocular drug delivery technologies.

• AG-120 (Ivosidenib) in AML: Protocols, Resistance, and Innov

  2026-06-16

  AG-120 (Ivosidenib) uniquely targets mutant IDH1 in AML, enabling robust oncometabolite suppression and myeloid differentiation. Recent insights into CD44-mediated metabolic rewiring open new avenues for overcoming resistance and optimizing experimental workflows.

• Transmission Dynamics of Carbapenemase Genes in CREC: New In

  2026-06-15

  This study details the molecular epidemiology and transmission mechanisms of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. It highlights the predominance of plasmid-borne blaNDM-1, high rates of multidrug resistance, and substantial horizontal gene transfer, providing crucial evidence for antimicrobial resistance research.

• Apigenin (N1828): Epigenetic Precision and Neuro-Oncological

  2026-06-15

  Explore the multi-dimensional potential of Apigenin, a plant-derived HDAC inhibitor, in malignant mesothelioma and Alzheimer’s research. This article delivers a unique, mechanistically rich analysis of 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one, integrating recent network medicine insights and advanced assay guidance.

• BAPTA-AM: Cell-Permeable Calcium Chelator for Precision Assa

  2026-06-14

  BAPTA-AM from APExBIO empowers researchers with precise, cell-permeable calcium chelation for advanced apoptosis, neuroprotection, and signaling assays. This guide details optimized protocols, highlights troubleshooting strategies, and interprets recent mechanistic findings to enhance experimental reproducibility and sensitivity.

• Optimizing Apoptosis Assays with MCL-1 Inhibitor A-1210477

  2026-06-13

  MCL-1 inhibitor A-1210477 empowers cancer researchers to dissect mitochondrial apoptosis with unprecedented selectivity and reproducibility. Learn how to streamline experimental workflows, troubleshoot solubility challenges, and enhance synergy in combination studies using this potent BH3 mimetic from APExBIO.

• SARS-CoV-2 N Protein Disrupts GADD34-Driven Antiviral Immuni

  2026-06-12

  The study by Liu et al. uncovers how the SARS-CoV-2 nucleocapsid protein suppresses the host's innate immune response by sequestering GADD34 mRNA within novel stress granule-like foci, impairing IRF3-driven interferon signaling. This mechanism highlights a sophisticated viral strategy to antagonize antiviral defense and offers new insights for antiviral research.

• Rhodamine B Applications: Advanced Tracing & Drift Analysis

  2026-06-12

  Rhodamine B (Basic Violet 10) unlocks robust, quantitative tracing in both environmental and cell biology workflows. From pioneering UAV pesticide drift studies to high-resolution cell labeling, this guide translates recent research into actionable protocols and troubleshooting strategies.

• Lumiracoxib in Precision COX-2 Assays: Advanced Mechanistic

  2026-06-11

  Explore how Lumiracoxib, a selective COX-2 inhibitor, enables advanced analysis of cyclooxygenase-2 pathway modulation in inflammation and vascular regeneration models. Discover unique mechanistic insights and practical assay guidance not found in other reviews.

• Caffeine (1,3,7-trimethylpurine-2,6-dione) in Cancer and Met

  2026-06-11

  Caffeine, a well-characterized adenosine receptor antagonist, is unlocking new potential in cancer cell line inhibition and metabolic modulation across both in vitro and in vivo systems. This article delivers actionable workflow guidance, practical troubleshooting, and strategic insights for maximizing research value with APExBIO's high-purity caffeine.

• Biotin-HPDP in Redox Proteomics: Reversible Thiol Labeling U

  2026-06-10

  Explore the advanced use of Biotin-HPDP for reversible, thiol-specific protein labeling in redox proteomics. This deep dive highlights unique mechanistic insights and practical guidance for optimizing biotinylation in complex neurodegenerative research.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page